Table 1.
Patient characteristics.
| HCV (n = 39) | Uninfected | ||
|---|---|---|---|
| Elderly (n = 30) | Adult Young (n = 40) | ||
| Age, years median, (min, max), (Q1, Q3) | 59 (28–74) (55, 65) | 77 (67–89) (72, 82) | 34 (23–50) (28, 43) |
| Gender (%) | |||
| Male | 94.9 | 100 | 71.8 |
| Female | 5.1 | 0 | 28.2 |
| Race (%) | |||
| White, non-Hispanic | 46.2 | 76.7 | 94.9 |
| Black, non-Hispanic | 51.3 | 23.3 | 0 |
| Hispanic (regardless of race) | 2.6 | 0 | 2.6 |
| Indian/Asian | 0 | 0 | 2.6 |
| Albumin median, (Q1, Q3) | 3.7, (3.5, 3.9) | 3.7 (3.4, 3.9) | N/A |
| ALT median, (Q1, Q3) | 43 (24, 85.5) | 26 (21.8, 31.2) | N/A |
| AST median, (Q1, Q3) | 29 (20, 51) | 18 (16.3, 22.3) | N/A |
| PLT median, (Q1, Q3) | 213 (177.3, 262.3) | 200 (178, 255) | N/A |
| APRI score median, (Q1, Q3) | 0.46 (0.24, 1.50) | 0.18 (0.12, 0.24) | N/A |
| Transient elastography (TE) (kPa) No/total, (%) | |||
| >12.5 kPa | 10/35 (28.6) | ||
| 9.5–12.5 | 3/35 (8.6) | ||
| <9.5 | 22/35 (62.9) | ||
| HCV viral load (IU/mL) median, (Q1, Q3) | 863,484 (42,864, 884,661) | N/A | N/A |
| HCV genotype No/total (%) | |||
| 1 | 3/35 (8.6) | ||
| 1a | 19/35 (54.3) | ||
| 1b | 7/35 (20.0) | ||
| 2 | 3/35 (8.6) | ||
| 3 | 3/35 (8.6) | ||
min = minimum; max = maximum; Q1 = quartile 1; ALT = alanine transaminase; AST-aspartate transaminase; PLT = platelet count; APRI = AST to platelet ratio index; IU = international units; N/A = not available.